December 15, 2021
A brand-new technique—fluorescence-detected mid-infrared photothermal microscopy (F-PTIR)—combines the resolution and sensitivity of fluorescence microscopy with the specificity of infrared (IR) spectroscopy.
December 15, 2021
What makes pancreatic cancer so deadly is its covert and quick spread. Now, a “time machine” built by Purdue University engineers has shown a way to reverse the course of cancer before it spreads throughout the pancreas.
Scientists Create “Time Machine” Made of Human Cells To Reverse Pancreatic Cancer Progression
December 15, 2021
Pancreatic cancer it is so dangerous because it stays “hidden” for a long time, and when it is activated it spreads very quickly. It seems that it is theoretically possible to master this process, as reported by scientists from Purdue University. They created a kind of “time machine” that it inhibits tumor progression.
December 14, 2021
To halt the progression of pancreatic cancer, scientists have created a “time machine” made of human cells.
December 13, 2021
Purdue University researchers have developed a test that allows for quicker diagnosis and pinpointed treatment of bovine respiratory disease, the most common and costly disease affecting the world’s cattle.
Purdue researchers develop quick test to spot most costly bovine disease
December 10, 2021
The newest distinguished professor in the Purdue University College of Veterinary Medicine is Dr. J. Paul Robinson, a faculty member in the Department of Basic Medical Sciences and director of the Purdue University Cytometry Laboratories. The Purdue University Board of Trustees ratified Dr. Robinson’s appointment as Distinguished Professor of Cytometry last Friday, December 3.
Purdue Trustees Ratify Appointment of Dr. J. Paul Robinson as Distinguished Professor of Cytometry
December 10, 2021
Three Purdue faculty members – Mingji Dai, Haley Oliver and Yuan Yao – have been appointed as Showalter Faculty Scholars. As of July, they joined 11 additional Showalter Scholars appointed in prior years at Purdue West Lafayette. The Showalter Trust programs at Purdue also have named 11 early career faculty members for 2021 grants to support their research projects. The Ralph W. and Grace M. Showalter Research Trust Fund annually provides funding to Purdue in support of scientific and medical research. In addition to selecting midcareer professionals as Showalter Faculty Scholars and providing one-year funding for early career professionals, the trust also supports two Showalter Distinguished Professors at Purdue, Charles Bouman and Kinam Park.
Showalter Trust honors three new scholars, funds 11 early career faculty
December 9, 2021
Sous-vide cooking inspired an idea that took promising technology out of the lab and into the barn. Researchers at Purdue University successfully developed an on-site bovine respiratory disease test that provides results within an hour.
Pen-side test for bovine respiratory disease could save industry millions
December 8, 2021
Detecting fatal repository disease in cattle is becoming quicker than ever with a new on-site testing method. A Purdue research team, led by assistant professor Mohit Verma, has successfully developed an easy-to-read test that produces results in as little as one hour.
Catch bovine respiratory disease at the pen-side in as little as an hour
December 8, 2021
omicron Just as the world tried starting to “live with Covid”, easing restrictions and reopening borders to international travel, emergence of a new variant in South Africa froze everything again. Is this never going to end? Are we bound to spend year after year under ever-changing pandemic restrictions, wearing masks, checking in to shopping malls, and getting regular vaccination boosters? Hopefully not and, paradoxically, Omicron may actually herald the beginning of the end of the pandemic and our return to normalcy. Few people may remember this now, but back in 2020 — long before we had vaccines and many expressed their skepticism about them ever being developed — scientists suggested that we should get ready for ongoing mutations of the virus, as it adapts to us and our environment. Those mutations, however, need not be more lethal. “…mutating to become more lethal to humans wouldn’t necessarily be in the virus’ best interests. If a virus goes in and immediately kills its host, that’s usually not very good because that limits its ability to expand and infect new hosts.” Richard Kuhn, a virologist and director of the Purdue Institute of Inflammation, Immunology and Infectious Disease in West Lafayette, Indiana, March 25, 2020 for Popular Science
The variant of hope: Omicron may help us end the pandemic and the coming weeks are crucial
